IGF1R and lung cancer: The binding prevents the translational inhibition of epidermal growth factor receptor (EGFR) and insulin-like growth factor 1 receptor (IGF1R), which both are essential cellular oncogenic proteins that drive carcinogenesis in human cancers such as lung cancer [38].